Kyle Thompson

1.6k total citations
23 papers, 563 citations indexed

About

Kyle Thompson is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Kyle Thompson has authored 23 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Clinical Biochemistry and 2 papers in Genetics. Recurrent topics in Kyle Thompson's work include Mitochondrial Function and Pathology (16 papers), Metabolism and Genetic Disorders (15 papers) and RNA modifications and cancer (10 papers). Kyle Thompson is often cited by papers focused on Mitochondrial Function and Pathology (16 papers), Metabolism and Genetic Disorders (15 papers) and RNA modifications and cancer (10 papers). Kyle Thompson collaborates with scholars based in United Kingdom, United States and Germany. Kyle Thompson's co-authors include Robert W. Taylor, Monika Oláhová, Robert McFarland, Charlotte L. Alston, Angela Pyle, Emma L. Blakely, Jack J. Collier, Fiona Robertson, Langping He and P.P.A. Humphrey and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Human Molecular Genetics.

In The Last Decade

Kyle Thompson

22 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Thompson United Kingdom 14 448 196 58 44 42 23 563
Nicole Lesko Sweden 11 511 1.1× 154 0.8× 79 1.4× 45 1.0× 43 1.0× 23 652
Maria Chiara Meschini Italy 15 461 1.0× 242 1.2× 64 1.1× 91 2.1× 121 2.9× 23 637
María Teresa García‐Silva Spain 12 392 0.9× 234 1.2× 71 1.2× 32 0.7× 83 2.0× 24 595
Laura Melchionda Italy 11 475 1.1× 174 0.9× 31 0.5× 52 1.2× 35 0.8× 12 605
Anthony S. Castanza United States 5 410 0.9× 121 0.6× 46 0.8× 32 0.7× 111 2.6× 5 534
Helene Bruhn Sweden 11 346 0.8× 127 0.6× 60 1.0× 24 0.5× 19 0.5× 19 433
David Alsina Sweden 7 366 0.8× 101 0.5× 31 0.5× 59 1.3× 77 1.8× 9 480
Maja Di Rocco Italy 12 212 0.5× 122 0.6× 69 1.2× 32 0.7× 131 3.1× 20 459
Michela Ripolone Italy 13 349 0.8× 67 0.3× 63 1.1× 121 2.8× 74 1.8× 40 526
Marris G. Dibley Australia 4 502 1.1× 132 0.7× 38 0.7× 31 0.7× 52 1.2× 4 585

Countries citing papers authored by Kyle Thompson

Since Specialization
Citations

This map shows the geographic impact of Kyle Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Thompson more than expected).

Fields of papers citing papers by Kyle Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Thompson. The network helps show where Kyle Thompson may publish in the future.

Co-authorship network of co-authors of Kyle Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Thompson. A scholar is included among the top collaborators of Kyle Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Thompson. Kyle Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarn, Jessica, John Casement, Dennis Lendrem, et al.. (2024). Stability of symptom-based subtypes in Sjogren’s disease. RMD Open. 10(4). e004914–e004914.
2.
Smith, Thomas B., Huw B. Thomas, Kyle Thompson, et al.. (2023). Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54. European Journal of Human Genetics. 31(10). 1190–1194. 3 indexed citations
3.
Chen, Wenqian, Kyle Thompson, Karen Stals, et al.. (2023). Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease. Molecular Genetics and Metabolism. 140(3). 107657–107657. 2 indexed citations
4.
Thompson, Kyle, David A. Stroud, David R. Thorburn, & Robert W. Taylor. (2023). Investigation of oxidative phosphorylation activity and complex composition in mitochondrial disease. Handbook of clinical neurology. 194. 127–139. 3 indexed citations
5.
Thompson, Kyle, Emanuele Bellacchio, Courtney E. French, et al.. (2021). Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease. Human Molecular Genetics. 31(4). 523–534. 13 indexed citations
6.
Ng, Yi Shiau, Kyle Thompson, Sila Hopton, et al.. (2020). Novel MT-ND Gene Variants Causing Adult-Onset Mitochondrial Disease and Isolated Complex I Deficiency. Frontiers in Genetics. 11. 24–24. 16 indexed citations
7.
Nasca, Alessia, Juliana Heidler, Kyle Thompson, et al.. (2020). Bi‐allelic pathogenic variants in NDUFC2 cause early‐onset Leigh syndrome and stalled biogenesis of complex I. EMBO Molecular Medicine. 12(11). e12619–e12619. 22 indexed citations
8.
Sommerville, Ewen W., Ilaria Dalla Rosa, Masha M. Rosenberg, et al.. (2019). Identification of a novel heterozygous guanosine monophosphate reductase ( GMPR ) variant in a patient with a late‐onset disorder of mitochondrial DNA maintenance. Clinical Genetics. 97(2). 276–286. 7 indexed citations
9.
Thompson, Kyle, Jack J. Collier, Fiona Robertson, et al.. (2019). Recent advances in understanding the molecular genetic basis of mitochondrial disease. Journal of Inherited Metabolic Disease. 43(1). 36–50. 112 indexed citations
10.
Agnew, Thomas, Michelle Goldsworthy, Carlos Aguilar, et al.. (2018). A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways. Cell Reports. 25(12). 3315–3328.e6. 32 indexed citations
11.
King, Martin, Kyle Thompson, Sila Hopton, et al.. (2018). Expanding the phenotype of de novo SLC25A4 -linked mitochondrial disease to include mild myopathy. Neurology Genetics. 4(4). e256–e256. 16 indexed citations
12.
Zagnoli-Vieira, Guido, Francesco Bruni, Kyle Thompson, et al.. (2018). Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23). Neurology Genetics. 4(4). e262–e262. 30 indexed citations
13.
Thompson, Kyle, Inês A. Barbosa, Langping He, et al.. (2017). Novel GFM2 variants associated with early-onset neurological presentations of mitochondrial disease and impaired expression of OXPHOS subunits. Neurogenetics. 18(4). 227–235. 12 indexed citations
14.
Oláhová, Monika, Kyle Thompson, Steven Hardy, et al.. (2016). Pathogenic variants in HTRA2 cause an early‐onset mitochondrial syndrome associated with 3‐methylglutaconic aciduria. Journal of Inherited Metabolic Disease. 40(1). 121–130. 23 indexed citations
15.
Oliveira, Renata Maria Souza, Ewen W. Sommerville, Kyle Thompson, et al.. (2016). Lethal Neonatal LTBL Associated with Biallelic EARS2 Variants: Case Report and Review of the Reported Neuroradiological Features. JIMD Reports. 33. 61–68. 17 indexed citations
16.
Thompson, Kyle. (2016). Seasonal Distributions of Wildlife Inhabiting the Madrean Archipelago. UA Campus Repository (The University of Arizona). 1 indexed citations
17.
Casey, Jillian P., Ellen Crushell, Kyle Thompson, et al.. (2015). Periventricular Calcification, Abnormal Pterins and Dry Thickened Skin: Expanding the Clinical Spectrum of RMND1?. JIMD Reports. 26. 13–19. 5 indexed citations
18.
Thompson, Kyle, Jaume Campistol, Steven Hardy, et al.. (2015). Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations. Frontiers in Genetics. 6. 102–102. 14 indexed citations
19.
Bargagna‐Mohan, Paola, Sunil Deokule, Kyle Thompson, et al.. (2013). Withaferin A Effectively Targets Soluble Vimentin in the Glaucoma Filtration Surgical Model of Fibrosis. PLoS ONE. 8(5). e63881–e63881. 29 indexed citations
20.
Thompson, Kyle, et al.. (2001). Species- and agonist-dependent differences in the deactivation-kinetics of P2X 7 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(6). 639–648. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Lesko Breakdown of academic impact, for papers by Maria Chiara Meschini Breakdown of academic impact, for papers by María Teresa García‐Silva Breakdown of academic impact, for papers by Laura Melchionda Breakdown of academic impact, for papers by Anthony S. Castanza Breakdown of academic impact, for papers by Helene Bruhn Breakdown of academic impact, for papers by David Alsina Breakdown of academic impact, for papers by Maja Di Rocco Breakdown of academic impact, for papers by Michela Ripolone Breakdown of academic impact, for papers by Marris G. Dibley
Rankless by CCL
2026